ENOV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Enovis Corp (ENOV) is not a strong buy at this time for a beginner investor with a long-term strategy. While there are some positive catalysts such as insider buying and improving gross margins, the company's weak financial performance, bearish technical indicators, and lack of significant positive trading signals suggest a cautious approach. The stock may be better suited for monitoring rather than immediate investment.
The technical indicators for ENOV are bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 57.072, and moving averages indicate a bearish trend with SMA_200 > SMA_20 > SMA_5. The stock is trading near its pivot level of 22.868, with resistance at 24.029 and support at 21.706.
Insiders are buying, with a 372.22% increase in buying activity over the last month. Analysts have maintained positive ratings with price targets significantly above the current price, indicating potential upside.
The company's financial performance in Q4 2025 shows a significant decline in net income (-25.98% YoY) and EPS (-27.66% YoY), despite a slight revenue increase. The stock has a bearish technical setup and lacks recent news or event-driven catalysts. Additionally, no significant hedge fund activity or congress trading data is available.
In Q4 2025, revenue increased by 2.64% YoY to $575.76M, but net income dropped by 25.98% YoY to -$520.59M. EPS fell by 27.66% YoY to -9.1. Gross margin improved by 6.33% YoY to 53.93%. Overall, the financial performance shows weak profitability despite slight revenue growth.
Analysts have maintained positive ratings with price targets ranging from $40 to $42, which is significantly above the current price of $23.37. Analysts highlight the company's potential for recovery in end markets and improving financial profile but acknowledge concerns about cash flow and exposure to mature markets.
